Non-Isolated Neural Tube Defects with Comorbid Malformations Are Responsive to Population-Level Folic Acid Supplementation in Northern China
Open Access
Abstract
Objective: Comorbid congenital malformation of multiple organs may indicate a shared genetic/teratogenic causality. Folic acid supplementation reduces the population-level prevalence of isolated neural tube defects (NTDs), but whether complex cases involving independent malformations are also responsive is unknown. We aimed to describe the epidemiology of NTDs with comorbid malformations in a Chinese population and assess the impact of folic acid supplementation. Study Design: Data from five counties in Northern China were obtained between 2002 and 2021 through a population-based birth defects surveillance system. All live births, stillbirths, and terminations because of NTDs at any gestational age were recorded. NTDs were classified as spina bifida, anencephaly, or encephalocele. Isolated NTDs included spina bifida cases with presumed secondary malformations (hydrocephalus, hip dislocation, talipes). Non-isolated NTDs were those with independent concomitant malformations. Results: A total of 296,306 births and 2031 cases of NTDs were recorded from 2002–2021. A total of 4.8% of NTDs (97/2031) had comorbid defects, which primarily affected the abdominal wall (25/97), musculoskeletal system (24/97), central nervous system (22/97), and face (15/97). The relative risk of cleft lip and/or palate, limb reduction defects, hip dislocation, gastroschisis, omphalocele, hydrocephalus, and urogenital system defects was significantly greater in infants with NTDs than in the general population. Population-level folic acid supplementation significantly reduced the prevalence of both isolated and non-isolated NTDs. Conclusion: Epidemiologically, non-isolated NTDs follow similar trends as isolated cases and are responsive to primary prevention by folic acid supplementation. Various clinically-important congenital malformations are over-represented in individuals with NTDs, suggesting a common etiology.Keywords
All Related Versions
Funding Information
- Ministry of Science and Technology, Taiwan (2021YFC2701001, 2021YFC2701101, BMU2021YJ034, 81973056, 211112/Z/18/Z)
- Ministry of Science and Technology from P.R. China (2021YFC2701001, 2021YFC2701101, BMU2021YJ034, 81973056, 211112/Z/18/Z)
- the Fundamental Research Funds for the Central Universities (2021YFC2701001, 2021YFC2701101, BMU2021YJ034, 81973056, 211112/Z/18/Z)
- National Natural Science Foundation of China (2021YFC2701001, 2021YFC2701101, BMU2021YJ034, 81973056, 211112/Z/18/Z)
- Wellcome (2021YFC2701001, 2021YFC2701101, BMU2021YJ034, 81973056, 211112/Z/18/Z)
This publication has 34 references indexed in Scilit:
- Long Term Maintenance of Neural Tube Defects Prevention in a High Prevalence StateThe Journal of Pediatrics, 2011
- Folic acid supplementation can adversely affect murine neural tube closure and embryonic survivalHuman Molecular Genetics, 2011
- Disruption of PCP signaling causes limb morphogenesis and skeletal defects and may underlie Robinow syndrome and brachydactyly type BHuman Molecular Genetics, 2010
- Folic acid flour fortification: Impact on the frequencies of 52 congenital anomaly types in three South American countriesAmerican Journal of Medical Genetics Part A, 2010
- Anomalous development of brain structure and function in spina bifida myelomeningoceleDevelopmental Disabilities Research Reviews, 2010
- Understanding the causes and prevention of neural tube defects: Insights from the splotch mouse modelBirth Defects Research Part A: Clinical and Molecular Teratology, 2009
- Extremely high prevalence of neural tube defects in a 4‐county area in Shanxi Province, ChinaBirth Defects Research Part A: Clinical and Molecular Teratology, 2006
- Vitamin supplements and the risk for congenital anomalies other than neural tube defectsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2004
- Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. EUROCAT Working Group.Journal of Epidemiology and Community Health, 1991
- CNS anomalies and the midline as a “developmental field”American Journal of Medical Genetics, 1982